Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

175
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
175
Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

180
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
180
Sampling Plans01:23

Sampling Plans

180
Sampling is a crucial step in analytical chemistry, allowing researchers to collect representative data from a large population. Common sampling methods include random, judgmental, systematic, stratified, and cluster sampling.
Random sampling is a method where each member of the population has an equal chance of being selected for the sample. It involves selecting individuals randomly, often using random number generators or lottery-type methods. For example, when analyzing the properties of a...
180
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

36
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
36
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

406
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
406
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data01:16

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data

120
Statistical inference techniques, paramount in hypothesis testing, differentiate into two broad categories: parametric and nonparametric statistics.
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance,...
120

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mind the Gap: A Sequential 4-Step Missing Data Management for CGM-Derived Endpoints in Diabetes Clinical Trials.

Journal of diabetes science and technology·2026
Same author

Tuina ameliorates sleep disturbances in PCPA-treated rats through Piezo1-mediated calcium signaling.

Frontiers in pharmacology·2026
Same author

Beyond Time in Range: Hidden Statistical Challenges of Continuous Glucose Monitoring Data in Diabetes Drug Development.

Journal of diabetes science and technology·2025
Same author

Ni/Co Bimetallic Nanoparticles on Co<sub>3</sub>O<sub>4</sub> Nanoarrays Bridged by CNTs for High Oxygen Evolution Reaction.

ACS applied materials & interfaces·2025
Same author

Application of Bayesian Borrowing Methods in Clinical Trials for Children with Type II Diabetes Mellitus.

Therapeutic innovation & regulatory science·2025
Same author

Application of Bayesian statistics to support approval of intravenous belimumab in children with systemic lupus erythematosus in the United States.

Lupus·2025
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
查看所有相关文章

相关实验视频

Updated: Jun 21, 2025

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.3K

贝叶斯分层模型用于子组分析.

Yun Wang1, Wenda Tu1, William Koh1

  • 1Department of Health and Human Services, Office of Biostatistics, Center for Drug Evaluation and Research, FDA, Silver Spring, Maryland, USA.

Pharmaceutical statistics
|July 16, 2024
PubMed
概括
此摘要是机器生成的。

与传统方法相比,贝叶斯等级模型为子组治疗效应估计提供了更高的精度. 这些模型利用跨子组的数据,减少变化,为药物开发提供更可靠的结果.

关键词:
贝叶斯的等级模型是贝叶斯的等级模型.药物试验快照 药物试验快照收缩分析是一种分析.

更多相关视频

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.3K
Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations
08:03

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Published on: December 7, 2021

2.1K

相关实验视频

Last Updated: Jun 21, 2025

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.3K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.3K
Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations
08:03

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations

Published on: December 7, 2021

2.1K

科学领域:

  • 生物统计学 生物统计学
  • 临床试验方法论 临床试验方法论
  • 制药指标 (Pharmacometrics) 是一个指标.

背景情况:

  • 传统的子组分析可以在每个子组内独立估计治疗效果.
  • 这种方法可以导致异质和高可变性估计,特别是在小子组样本大小的情况下.
  • 小组估计可能与整体人口治疗效应有很大差异.

研究的目的:

  • 介绍和详细介绍贝叶斯层次模型 (BHM) 对于子组分析的应用.
  • 为了证明BHM如何能够产生更精确,更少异质的小组治疗效果估计.
  • 用现实世界的案例研究来说明BHM在药物开发中的实用性.

主要方法:

  • 讨论实施单向和多向BHM的技术细节.
  • 使用汇总级统计数据和患者级数据应用BHM.
  • 利用了来自新药应用的四个案例研究,涵盖了不同的终点类型.

主要成果:

  • 贝叶斯的等级模型提供了对子组治疗效应的更精确的估计.
  • BHM减少了子组效应估计中的异质性和变异性.
  • 估计的子组效应通常更接近整体人口治疗效应.

结论:

  • 贝叶斯的层次模型是临床试验中常规方法对子组分析的优越替代方案.
  • BHM有效地整合了跨子组的信息,提高了治疗效果估计的可靠性.
  • 该方法适用于各种终点类型 (连续,二分类型,时间到事件,计数) 和数据结构.